COVID-19 vaccine acceptance and associated factors among people living with HIV in the Middle East and North Africa region

Mohamed, Rahma; White, Trenton M; Lazarus, Jeffrey V.; Salem, Amany A.; Kaki, Reham; Marrakchi, W.; Kheir, Sara Gabrallah Mohamed; Amer, Ibrahim; Ahmed, Fida M; Khayat, Maie Abdulrhman; Al-Abdullah, Nabeela; Ali, Batool; Sultan, Roaa; Alamri, Bandar; Abdulmajid, Anouf; Kooli, I.; Chakroun, M.; Madani, Tariq A.; Esmat, Gamal; Cordie, Ahmed

doi:10.4102/sajhivmed.v23i1.1391

Cited by 12 publications

(7 citation statements)

References 37 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This finding is higher than a study conducted in 2021 in eight major cities in China, where only 57.2% of patients were willing to be vaccinated [ 10 ]. This number is also higher than the report from a study in the Middle East and North Africa between March and August 2021, which stated a vaccine acceptance rate of 64.6% among PLHIV [ 25 ]. The current study started in September 2021, several months after the initiation of the COVID-19 vaccination program for the general population in Indonesia.…”

Section: Discussionmentioning

confidence: 59%

Predicting Intention to Receive COVID-19 Vaccination in People Living with HIV using an Integrated Behavior Model

et al. 2023

View full text Add to dashboard Cite

People living with HIV (PLHIV) are considered a high-risk population for developing a severe form of COVID-19. Vaccination is still one of the most important modalities in combating the disease due to the lack of an effective treatment. This multicenter study was performed from September to December 2021 with the aim to analyze the intention of PLHIV to receive the COVID-19 vaccination based on an integrated behavior model (IBM) in Indonesia. Of a total of 470 participants, 75.6% of patients were intent to be vaccinated. The model that was designed in this study explains 43.4% of the variance in intention to be vaccinated against COVID-19 in PLHIV (adjusted R2 = 0.434). Furthermore, the determinants used included instrumental attitude (β = 0.127, p < 0.05), subjective norm (β = 0.497, p < 0.01), and perceived behavioral control (β = 0.116, p < 0.01). This study concluded that an IBM could predict the intention of PLHIV to receive COVID-19 vaccination.

show abstract

Section: Discussionmentioning

confidence: 59%

Predicting Intention to Receive COVID-19 Vaccination in People Living with HIV using an Integrated Behavior Model

et al. 2023

View full text Add to dashboard Cite

show abstract

“…However, the acceptance rate among PLHIV is considerably lower than the WHO target of 100%, in contrast to the rate for the general population (70%). Concerns about vaccine safety in PLHIV, particularly related to drugdrug interactions with ART medications, may contribute to this disparity [38,39]. Education and trust-building are crucial to increase vaccine acceptance among PLHIV.…”

Section: Discussionmentioning

confidence: 99%

COVID‐19 vaccine acceptance among people living with HIV: A systematic review and meta‐analysis

Ejamo,

Legese,

Tesfaye

et al. 2023

Tropical Med Int Health

View full text Add to dashboard Cite

Objective: To assess coronavirus disease 2019 (COVID-19) vaccine acceptance among people living with HIV (PLHIV) worldwide. Methods: We searched MEDLINE, PSYINFO, CINHAL, Scopus and EMBASE databases and other sources including free Google search and subject-specific journals from January 2020 to September 2021. The study population included adults (aged 18+ years) living with HIV and evaluated for COVID-19 vaccine acceptance. A random effect meta-analysis model was used to estimate the pooled COVID-19 vaccine acceptance rate. Subgroup analyses were performed, and factors associated with COVID-19 vaccine hesitancy underwent narrative analysis. Of 558 initial records, 14 studies were eligible for review. Results: The overall pooled COVID-19 vaccine acceptance rate among adult PLHIV was 62% (95% confidence interval [CI], 56%-69%). In subgroup analysis, the estimated pooled COVID-19 vaccine acceptance rate was higher in high-income countries: 63% (95% CI, 55%-70%) versus 62% (95% CI, 54%-71%) in low-and middle-income countries, and in studies conducted in 2022 (66% [95% CI, 58%-75%]) than in studies conducted in 2021 (57% [95% CI, 47%-68%]). Reasons for lower COVID-19 vaccine acceptance included higher monthly income, being non-homosexual, history of chronic disease, COVID-19-related medical mistrust, not knowing anyone who died of COVID-19, believing oneself to be immune to COVID-19, general vaccine refusal, negative attitude to the vaccine, concerns about efficacy, safety and side effects, distrust in common sources of vaccine-related information and using social media as a source of information on COVID-19. Conclusion: Among PLHIV, acceptance of COVID-19 vaccine is generally low. A greater emphasis on collaborative efforts between all concerned bodies is needed to boost vaccine acceptance in this population.

show abstract

“…Based on previous research, 68.4% of the global population is willing to receive the COVID-19 vaccination (19), and the acceptance of the COVID-19 vaccine varied extensively among different countries, ranging from 54.85% in Russia to 88.62% in China (20). Among PLWH, studies in China (which included eight cities but not Shijiazhuang) (21) and in the Middle East and North Africa region (22) have shown that the proportion of people willing to receive the COVID-19 vaccination was 57.2 and 64.6%, respectively. Therefore, to achieve early herd immunization, it is important to understand people's willingness to receive the COVID-19 vaccination.…”

Section: Introductionmentioning

confidence: 99%

COVID-19 vaccination willingness among people living with HIV in Shijiazhuang, China: a cross-sectional survey

Zhang,

Zhan,

Wang

et al. 2024

Front. Med.

View full text Add to dashboard Cite

ObjectivesThe COVID-19 pandemic imposed an enormous disease and economic burden worldwide. SARS-CoV-2 vaccination is essential to containing the pandemic. People living with HIV (PLWH) may be more vulnerable to severe COVID-19 outcomes; thus, understanding their vaccination willingness and influencing factors is helpful in developing targeted vaccination strategies.MethodsA cross-sectional study was conducted between 15 June and 30 August 2022 in Shijiazhuang, China. Variables included socio-demographic characteristics, health status characteristics, HIV-related characteristics, knowledge, and attitudes toward COVID-19 vaccination and COVID-19 vaccination status. Multivariable logistic regression was used to confirm factors associated with COVID-19 vaccination willingness among PLWH.ResultsA total of 1,428 PLWH were included, with a 90.48% willingness to receive the COVID-19 vaccination. PLWH were more unwilling to receive COVID-19 vaccination for those who were female or had a fair/poor health status, had an allergic history and comorbidities, were unconvinced and unsure about the effectiveness of vaccines, were unconvinced and unsure about the safety of vaccines, were convinced and unsure about whether COVID-19 vaccination would affect ART efficacy, or did not know at least a type of domestic COVID-19 vaccine. Approximately 93.00% of PLWH have received at least one dose of the COVID-19 vaccine among PLWH, and 213 PLWH (14.92%) reported at least one adverse reaction within 7 days.ConclusionIn conclusion, our study reported a relatively high willingness to receive the COVID-19 vaccination among PLWH in Shijiazhuang. However, a small number of PLWH still held hesitancy; thus, more tailored policies or guidelines from the government should be performed to enhance the COVID-19 vaccination rate among PLWH.

show abstract

COVID-19 vaccine acceptance and associated factors among people living with HIV in the Middle East and North Africa region

Cited by 12 publications

References 37 publications

Predicting Intention to Receive COVID-19 Vaccination in People Living with HIV using an Integrated Behavior Model

Predicting Intention to Receive COVID-19 Vaccination in People Living with HIV using an Integrated Behavior Model

COVID‐19 vaccine acceptance among people living with HIV: A systematic review and meta‐analysis

COVID-19 vaccination willingness among people living with HIV in Shijiazhuang, China: a cross-sectional survey

Contact Info

Product

Resources

About